PIERRE FABRE MEDICAMENT PRODUCTION ,   France

Lyophilizate for the preparation of concentrate for the preparation of a solution for infusions, 50 mg.

Lyophilizate for the preparation of solution for intravenous and subcutaneous administration, 3.5 mg.

Tablets, prolonged action, coated.

Cream for external use 15%.

Pastilles [without sugar]. For 12 pastilles in a blister of PVC / PVDC / aluminum foil. For 1 or 2 blisters with instructions for use in a pack of cardboard.

Concentrate for the preparation of a solution for infusions of 10 mg / 1 ml.

Solution for intravenous administration 0.25 mg / 5 ml.

Capsules 160 mg.

Tablets of prolonged action, covered with sugar shell. 80 mg, 10 pieces in a blister of PVC / PVDC and aluminum foil, 3 blisters per cardboard pack with instructions for use.

Concentrate for the preparation of a solution for infusions of 30 mg.

For 30 mg / 1.2 ml in bottles of transparent glass with a nominal capacity of 4 ml, sealed with a rubber butyl rubber stopper coated with fluoropolymer and rolled aluminum cap, equipped plastic detachable cap.

According to 1.8 ml of solvent in bottles of transparent glass with a nominal capacity of 3 ml, sealed with a rubber butyl rubber stopper coated with fluoropolymer and rolled aluminum cap, equipped plastic detachable cap.

For 1 vial of concentrate with a solvent (1 bottle), together with instructions for use in a cardboard pack.